{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:55:16Z","timestamp":1780570516606,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/1469-0691.12362","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T03:44:38Z","timestamp":1377315878000},"page":"O188-O196","source":"Crossref","is-referenced-by-count":10,"title":["Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance"],"prefix":"10.1016","volume":"20","author":[{"given":"M.J.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nir-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12362_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1111\/1469-0691.12362_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1592\/phco.31.6.598","article-title":"Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum","volume":"31","author":"Traugott","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12362_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12362_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jhin.2010.11.024","article-title":"Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern france","volume":"77","author":"Miliani","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12362_bib5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1086\/605408","article-title":"The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit","volume":"200","author":"Johnson","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12362_bib6","unstructured":"Royal decree of April 26, 1999. Creation of belgian antibiotic coordination committee (bapcoc). Belgisch staatsblad July 31, 1999. 1999."},{"key":"10.1111\/1469-0691.12362_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12362_bib8","series-title":"Whonet 5.4: software for the management and analysis of microbiology laboratory results","author":"Stelling","year":"2007"},{"key":"10.1111\/1469-0691.12362_bib9","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement; m100-s20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1111\/1469-0691.12362_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/1469-0691.12362_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/dkf115","article-title":"Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa","volume":"50","author":"Higgins","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib13","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in europe","volume":"14","author":"van de Sande-Bruinsma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12362_bib17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkq525","article-title":"Modelling the impact of antibiotic use on antibiotic-resistant escherichia coli using population-based data from a large hospital and its surrounding community","volume":"66","author":"Vernaz","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib18","first-page":"291","article-title":"Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units","volume":"34","author":"Vojtova","year":"2011","journal-title":"New Microbiol"},{"key":"10.1111\/1469-0691.12362_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.01535-08","article-title":"Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa","volume":"53","author":"Pakyz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12362_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in finland. Finnish study group for antimicrobial resistance","volume":"337","author":"Seppala","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12362_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/jac\/dkg404","article-title":"Ertapenem, the first of a new group of carbapenems","volume":"52","author":"Shah","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib23","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1128\/AAC.00742-11","article-title":"Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study","volume":"55","author":"Cook","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12362_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/dks385","article-title":"Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in queensland, australia","volume":"68","author":"McDougall","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib26","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/jac\/dkt091","article-title":"Impact of ertapenem use on Pseudomonas aeruginosa and acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?","volume":"68","author":"Sousa","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2011.05.014","article-title":"Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems","volume":"79","author":"Park","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12362_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12362_bib29","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.00456-08","article-title":"Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa","volume":"52","author":"Patel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12362_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"Ampc beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12362_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.05.022","article-title":"Pseudomonas aeruginosa infections in the intensive care unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?","volume":"30","author":"Bhat","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12362_bib14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 3","key":"10.1111\/1469-0691.12362_bib15","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/321848","article-title":"Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies","volume":"33","author":"Steinke","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12362_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dks406","article-title":"Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes","volume":"68","author":"Gbaguidi-Haore","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1111\/1469-0691.12362_bib22","first-page":"ii11","article-title":"In vitro activity of ertapenem: review of recent studies","volume":"53","author":"Wexler","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12362_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2011.08.018","article-title":"Carbapenem stewardship: does ertapenem affect pseudomonas susceptibility to other carbapenems? A review of the evidence","volume":"39","author":"Nicolau","year":"2012","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14608533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14608533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T14:56:30Z","timestamp":1539442590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14608533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1198743X14608533"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12362","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}